NEW YORK, NY / ACCESSWIRE / January 10, 2019 / WeissLawLLP, a national
class action and shareholders' rights law firm with offices in New York, Los Angeles, and Atlanta, announces an investigation of
Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC). The investigation focuses on possible breaches of fiduciary duty
and violations of the Federal securities laws.
If you own Teladoc shares and wish todiscuss this investigation or have any questions
concerning this notice or yourrights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Visitour website
http://www.weisslawllp.com/teladoc-health-inc/
Orfollow us on Twitter @MarketsAlert
On December 5, 2018, the Southern Investigative Reporting Foundation published an article reporting that the Company's CFO, Mark
Hirschhorn ("Hirschhorn") engaged in an affair with a subordinate. During the course of their affair, the subordinate received
numerous promotions over more experienced and qualified colleagues, and information from Hirschhorn on "when he thought there were
good opportunities to sell some [Teladoc] shares." On that news, Teledoc shares nosedived $8.54 from their December 4 opening price
of $64.35 to close on December 6 at $55.81 per share.
WeissLaw is investigating whether Teladoc's Board breached its fiduciary duties to the Company's shareholders by making false
and/or misleading statements, and/or failing to disclose that: (i) Hirschhorn engaged in an inappropriate relationship with a
subordinate; (ii) Hirschhorn and the subordinate engaged in insider trading; (iii) Hirschhorn caused the subordinate to receive
promotions for which she was unqualified; and (iv) Hirschhorn's conduct negatively impacted the Company's operations. If you own
Teladoc shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests,
please contact Joshua Rubin of WeissLaw LLP at (888)593-4771, or by e-mail at stockinfo@weisslawllp.com.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many
of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider
trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false
advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at
stockinfo@weisslawllp.com.
SOURCE: WeissLaw LLP
